G Scotto

Summary

Affiliation: University of Foggia
Country: Italy

Publications

  1. doi request reprint Prevalence of antibodies to hepatitis E virus in immigrants: a seroepidemiological survey in the district of Foggia (Apulia-southern Italy)
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    J Med Virol 85:261-5. 2013
  2. ncbi request reprint Tuberculosis and immigrants: a SIMIT (Italian Society of Infectious Diseases) clinical, epidemiological multicentric research investigation
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia Luigi Pinto Street, 1 71100 Foggia, Italy
    New Microbiol 32:39-47. 2009
  3. doi request reprint Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    J Interferon Cytokine Res 28:623-9. 2008
  4. ncbi request reprint Prolonged lamivudine treatment in patients with chronic active anti-HBe-positive hepatitis
    Gaetano Scotto
    Infectious Diseases Unit, University of Foggia, Foggia, Italy
    Am J Ther 13:218-22. 2006
  5. ncbi request reprint Extended lamivudine treatment in patients affected by chronic active anti-Hbe positive hepatitis
    G Scotto
    Infectious Diseases Unit, University of Foggia, Italy
    J Chemother 18:43-8. 2006
  6. ncbi request reprint Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Italy
    New Microbiol 28:193-7. 2005
  7. ncbi request reprint [Epidemiologic multicenter study of the prevalence of hepatitis in hospitalised immigrants in Italy in the year 2002]
    G Scotto
    SIMIT Società Italiana di Malattie Infettive e Tropicali, Commissione per lo studio delle malattie infettive negli immigrati
    Ann Ig 17:11-8. 2005
  8. ncbi request reprint Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Italy
    New Microbiol 28:23-9. 2005
  9. ncbi request reprint Simit epidemiological multicentric study on hospitalized immigrants in Italy during 2002
    G Scotto
    SIMIT Italian Society of Infectious and Tropical Diseases Committee for Study of Infectious Diseases in Immigrants, Infectious Diseases Clinic, University of Foggia, Via Mastelloni 17, 71100 Foggia, Italy
    J Immigr Health 7:55-60. 2005
  10. ncbi request reprint Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports
    G Scotto
    Infectious Diseases Clinic, University of Foggia, via L Pinto 1, I 71100 Foggia, Italy
    Infection 33:30-2. 2005

Detail Information

Publications34

  1. doi request reprint Prevalence of antibodies to hepatitis E virus in immigrants: a seroepidemiological survey in the district of Foggia (Apulia-southern Italy)
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    J Med Virol 85:261-5. 2013
    ..The high prevalence of acute hepatitis involved mainly subjects who arrived in Italy during the same period from the same countries (Eritrea, Ethiopia, and Somalia)...
  2. ncbi request reprint Tuberculosis and immigrants: a SIMIT (Italian Society of Infectious Diseases) clinical, epidemiological multicentric research investigation
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia Luigi Pinto Street, 1 71100 Foggia, Italy
    New Microbiol 32:39-47. 2009
    ..In conclusion, TB still represents an important disease among immigrants. Improved living conditions, both in countries of origin and in Italy, especially in the first few years, would certainly decrease the incidence of TB...
  3. doi request reprint Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    J Interferon Cytokine Res 28:623-9. 2008
    ..6 mg/kg/day) for a period of at least 3 months...
  4. ncbi request reprint Prolonged lamivudine treatment in patients with chronic active anti-HBe-positive hepatitis
    Gaetano Scotto
    Infectious Diseases Unit, University of Foggia, Foggia, Italy
    Am J Ther 13:218-22. 2006
    ..LAM was well tolerated during the 3-year therapy in all patients. Patients with chronic active anti-HBe-positive hepatitis demonstrated that the LAM response rate tends to decrease over time due to the emergence of YMDD variants...
  5. ncbi request reprint Extended lamivudine treatment in patients affected by chronic active anti-Hbe positive hepatitis
    G Scotto
    Infectious Diseases Unit, University of Foggia, Italy
    J Chemother 18:43-8. 2006
    ..The authors conclude that the clinical benefit of lamivudine is greatest for patients without YMDD variants after 5 years of extended treatment...
  6. ncbi request reprint Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Italy
    New Microbiol 28:193-7. 2005
    ..We conclude that in patients with anti-HBe positive chronic hepatitis B resistant to lamivudine, a 48-week ADV treatment resulted in significant biochemical and virological improvement without major adverse effects...
  7. ncbi request reprint [Epidemiologic multicenter study of the prevalence of hepatitis in hospitalised immigrants in Italy in the year 2002]
    G Scotto
    SIMIT Società Italiana di Malattie Infettive e Tropicali, Commissione per lo studio delle malattie infettive negli immigrati
    Ann Ig 17:11-8. 2005
    ..To retrospectively evaluate the prevalence of hepatitis in immigrant patients hospitalised in 48 Italian Operative Unit of Infectious Diseases during 2002...
  8. ncbi request reprint Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Italy
    New Microbiol 28:23-9. 2005
    ..Peg-interferon treatment was better tolerated and provoked significantly fewer therapy discontinuations...
  9. ncbi request reprint Simit epidemiological multicentric study on hospitalized immigrants in Italy during 2002
    G Scotto
    SIMIT Italian Society of Infectious and Tropical Diseases Committee for Study of Infectious Diseases in Immigrants, Infectious Diseases Clinic, University of Foggia, Via Mastelloni 17, 71100 Foggia, Italy
    J Immigr Health 7:55-60. 2005
    ..Only a few tropical diseases were diagnosed and therefore the immigrant should not be considered as an infectious disease carrier...
  10. ncbi request reprint Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports
    G Scotto
    Infectious Diseases Clinic, University of Foggia, via L Pinto 1, I 71100 Foggia, Italy
    Infection 33:30-2. 2005
    ..No correlation was found between treatment response and pretreatment viral load, viral genotype, and interval between acute infection diagnosis and start of therapy...
  11. ncbi request reprint Prevalence of HIV infections in hospitalised immigrants in Clinics of Infectious Diseases in Italy: a multicentric survey
    G Scotto
    SIMIT, Italian Society of Infectious and Tropical Diseases, Committee for Immigrants Infectious Diseases Study, University of Foggia, Italy
    Infez Med 13:147-51. 2005
    ..9% of all cases). Most HIV-infected patients were unaware of their positivity. In conclusion, HIV infection represents one of the main health problems among immigrants, particularly of African origin...
  12. ncbi request reprint HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples
    A Saracino
    Clinic of Infectious Diseases, University of Foggia, Italy
    Virus Res 130:34-42. 2007
    ..01 for "11/25" rule, p=0.01 for geno2pheno and p=0.03 for PSSM). Due to viral mixtures and/or difficulties in genotype interpretation, current V3 sequence-based methods cannot accurately predict HIV-1 coreceptor use...
  13. ncbi request reprint Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection
    G Scotto
    Department of Infectious Diseases, University of Foggia, Foggia, Italy
    J Infect 52:294-9. 2006
    ..To assess the prevalence of cryoglobulinemia in three groups of patients: HCV-positive/HIV-negative, HCV/HIV co-infected and HIV mono-infected...
  14. ncbi request reprint Immigration and hepatitis B virus: epidemiological, clinical and therapeutic aspects
    E Palumbo
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    East Mediterr Health J 14:784-90. 2008
    ..Genotype distribution was as follows: E (20 cases), D (14 cases) and A (11 cases). Our study underscores the potential of migratory flow to introduce genotype non-D hepatitis B virus into our country...
  15. ncbi request reprint Access to HAART in HIV-infected immigrants: a retrospective multicenter Italian study
    A Saracino
    Clinic of Infectious Diseases, University of Foggia, v le L Pinto, 1 71100 Foggia, Italy
    AIDS Patient Care STDS 19:599-606. 2005
    ..018) and registered in the National Health Service (p = 0.014) were significantly more likely to receive HAART compared to illegal immigrants...
  16. ncbi request reprint Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    Drugs 68:791-801. 2008
    ....
  17. ncbi request reprint Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors
    A Saracino
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    J Med Virol 78:9-17. 2006
    ..013). The data confirm that previously unreported mutations are associated with antiretroviral drug experience and, more importantly, with a reduced susceptibility to NRTIs and NNRTIs...
  18. ncbi request reprint Interferon-alpha (IFN alpha) daily dose versus IFN alpha plus ribavirin for treatment-naive chronic hepatitis c patients infected by genotype 1b
    Gaetano Scotto
    Hepatology Unit, Department of Infectious Diseases, Ospedali Riuniti, Foggia, Italy
    BioDrugs 17:281-6. 2003
    ..Response was evaluated by monitoring serum alanine aminotransferase (ALT) and HCV-RNA levels during treatment and follow-up (12 months)...
  19. ncbi request reprint Intrabiliary rupture of a hydatid liver cyst: a case report
    A Saracino
    Clinic of Infectious Diseases, University of Foggia, Italy
    New Microbiol 27:301-3. 2004
    ....
  20. ncbi request reprint Association between HLA class II antigens and hepatitis C virus infection
    G Scotto
    UO Infectious Diseases, University of Foggia, Italy
    J Biol Regul Homeost Agents 17:316-21. 2003
    ....
  21. ncbi request reprint QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy
    Annalisa Saracino
    Clinic of Infectious Diseases, University of Foggia, Italy
    New Microbiol 32:369-76. 2009
    ..A high amount of discordance QFT-GIT+/TST- was described. QFT-GIT might increase the identification of LTBI cases among recent immigrants...
  22. ncbi request reprint [Epidemiology of tuberculosis in immigrant patients hospitalised in Infectious Diseases Units in Italy: multicentric study]
    Gaetano Scotto
    Unita Operativa di Malattie Infettive, Universita degli Studi di Foggia, Foggia, Italy
    Infez Med 12:245-51. 2004
    ....
  23. pmc Prevalence of Plasmodium spp. in malaria asymptomatic African migrants assessed by nucleic acid sequence based amplification
    Marianna Marangi
    Dipartimento PRIME, Universita di Foggia, Foggia, Italy
    Malar J 8:12. 2009
    ....
  24. ncbi request reprint Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy
    T Santantonio
    Clinic of Infectious Diseases, University of Bari, Bari, Italy
    Clin Infect Dis 43:1154-9. 2006
    ..The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated...
  25. ncbi request reprint The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines
    Sergio Carbonara
    Clinic of Infectious Diseases, University of Bari, Italy
    New Microbiol 31:1-18. 2008
    ..Herein, the authors review and discuss some of the main current guidelines for CAP management, highlighting their differences and similarities...
  26. ncbi request reprint Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis
    Emilio Palumbo
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    Braz J Infect Dis 11:311-3. 2007
    ..These genotypes are not the most prevalent in the South America and this is probably the expression of a possible geographical redistribution of HBV genotypes...
  27. ncbi request reprint Efficacy and tolerability of lamivudine alone versus lamivudine plus alpha-interferon for treatment of chronic active hepatitis B in patients with a precore-mutant variant
    Gaetano Scotto
    Clinic of Infectious Diseases, University of Foggia, Italy
    Infez Med 14:145-51. 2006
    ..Moreover, the combination therapy for 40 weeks after pre-treatment with lamivudine for 12 weeks did not increase the sustained response...
  28. ncbi request reprint Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis
    Emilio Palumbo
    Clinic of Infectious Diseases, University of Foggia, Italy
    Arq Gastroenterol 44:54-7. 2007
    ..The genetic heterogeneity of the HBV genome has been established and eight genotypes can be classified according to the criterion of >8% differences in the complete nucleotide sequence of the viral genome...
  29. ncbi request reprint Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis
    L Quarta
    Department of Rheumatology, University of Foggia Medical School, Foggia, Italy
    Rheumatol Int 28:495-8. 2008
    ..To our knowledge this is first case of a patient with TB discitis treated with Neridronate. Further studies are necessary to confirm the effectiveness of Neridronate treatment added to antiTB drugs in spondylodiscitis...
  30. ncbi request reprint [Prevalence of Plasmodium spp. in asymptomatic African immigrants assessed by nucleic acid sequence based amplification]
    Marianna Marangi
    Dipartimento PRIME, Universita di Foggia, Foggia, Italy
    Infez Med 18:12-9. 2010
    ..This study showed that a substantial proportion of people originating from malaria endemic countries harbour malaria parasites in their blood. If transmission conditions are available, they could be a reservoir...
  31. ncbi request reprint Multiple recurrences of vertebral hydatidosis: a case report
    Annalisa Saracino
    Clinic of Infectious Diseases, University of Foggia, Foggia, Italy
    New Microbiol 28:271-5. 2005
    ..The main clinical problems involved in the diagnosis and management of vertebral manifestations of hydatidosis are discussed in the light of the latest clinical research...
  32. ncbi request reprint Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial
    Alessandra Mangia
    Gastroenterology, Istituto di Ricovero e Cura a Carattere Scientifico, Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
    Hepatology 47:43-50. 2008
    ..1%, P = 0.14). The only predictive factor of SVR in RVR patients was advanced fibrosis. Conclusion: Variable treatment duration ensures SVR rates similar to those of standard treatment duration, sparing unnecessary side effects and costs...
  33. ncbi request reprint [Mixed cryoglobulinemia in HCV mono-infected and HCV/HIV co-infected patients]
    Gaetano Scotto
    Clinica di Malattie Infettive, Universita degli Studi di Foggia and Dipartimento di Laboratorio, Ospedali Riuniti di Foggia, Italy
    Infez Med 12:101-7. 2004
    ..In conclusion, mixed cryoglobulinemia may be detected in a similar rate in the two groups and HIV infection does not appear to play a significant role in cryoglobulin production...
  34. ncbi request reprint Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3
    Alessandra Mangia
    Gastroenterology Unit, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
    N Engl J Med 352:2609-17. 2005
    ..We hypothesized that in patients with hepatitis C virus (HCV) genotype 2 or 3 in whom HCV RNA is not detectable after 4 weeks of therapy, 12 weeks of treatment is as effective as 24 weeks...